Cambridge has been part of a successful £16 million bid to work with the MRC, GSK and four other UK universities in a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases that present a serious burden to patients. The Experimental Medicine Initiative to Explore New Therapies (EMINENT) network will be […]